Method of treatment of asthma using antibodies to complement component C5

Details for Australian Patent Application No. 2009222630 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Wang, Yi

Agent Freehills

Pub. Number AU-A-2009222630

Parent 2003270330

Filing date 8 October 2009

Wipo publication date 29 October 2009

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

22 October 2009 Complete Application Filed

29 October 2009 Application Open to Public Inspection

  Published as AU-A-2009222630

29 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application was refused. Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009222631-Field adjustable impact jar

2009222629-A Gaming Machine and Display Device